• Prescreening Protocol to Enroll in Food Allergy Clinical Studies at a Single Site

  This is a protocol for prescreening of participants who would like to be in clinical studies in our Center at Stanford.

  Investigator

  • Sayantani Sindher
  Now accepting new patients View Details

• Clinical Study Using Biologics to Improve Multi OIT Outcomes (COMBINE)

  Food allergy (FA) is a serious public health concern that causes potentially-life threatening reactions in affected patients. The prevalence of food allergy in the United States (U.S.) has increased substantially and now affects 15 million patients:4-8% of children (6 million children, 30% with multiple food allergies) and about 9% of adults. This is a prospective Phase 2, single-center, multi-allergen OIT study in participants with proven allergies to 2 or 3 different foods in which one must be a peanut. The total of participants in the clinical study will be 110, ages 4 to 55 years with a history of multiple food allergies of 2 to 3 different foods including peanut. Allergy will be confirmed by FA-specific IgE levels and positive skin prick test (SPT). Enrolled participants must be positive during the Double-blind Placebo-controlled Food challenge (DBPCFC) at or before the 300 mg (444 mg cumulative) dosing level of FA proteins.

  Investigator

  • R. Sharon Chinthrajah
  Now accepting new patients View Details